Atlas Trials

Achieving Optimal Medical Therapy Through Percutaneous Treatment of Secondary Mitral Regurgitation to Improve Outcome in Patients With HFrEF

Clinical trial NCT07758023 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07758023
Sponsor
University Medical Center Mainz
Status
NOT_YET_RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
Mitral Regurgitation FunctionalHeart Failure With Reduced Ejection Fraction (HFrEF)
Start date
2026-08-10
Primary completion
2030-09-30
Enrollment
520

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.